Literature DB >> 29314353

Preparation of Chiral Contiguous Epoxyaziridines and Their Regioselective Ring-Opening for Drug Syntheses.

Hui Mao1,2, Hyeonsu Jeong3, Jieun Yang3, Hyun-Joon Ha3, Jung Woon Yang1.   

Abstract

Synthetically valuable chiral (aziridin-2-yl)oxirane-3-carbaldehydes bearing three consecutive functional groups including aziridine, epoxide, and aldehyde were prepared from the stereoselective epoxidation of (aziridin-2-yl)acrylaldehydes with H2 O2 using organocatalyst (2R)- or (2S)-[diphenyl(trimethylsilyloxy)methyl]pyrrolidine as organocatalyst. The regioselective ring opening of aziridines and epoxides enabled us to achieve the highly efficient asymmetric synthesis of the antibiotic edeine D fragment 3-hydroxy-4,5-diaminopenatanoic acid, an intermediate for the formal synthesis of non-proteinogenic amino acid (-)-galantinic acid, and for potent antifungal agent (+)-preussin, and the medicinally important framework 3-hydroxy-2-hydroxymethylpyrrolidine.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  contiguous epoxyaziridine; drug synthesis; enantioselective epoxidation; regioselective ring-opening; scaffold diversity

Mesh:

Substances:

Year:  2018        PMID: 29314353     DOI: 10.1002/chem.201706161

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  3 in total

1.  Theoretical investigation of the regioselective ring opening of 2-methylaziridine. Lewis acid effect.

Authors:  Emna Cherni; Khaled Essalah; Néji Besbes; Manef Abderrabba; Sameh Ayadi
Journal:  J Mol Model       Date:  2018-10-09       Impact factor: 1.810

Review 2.  N-(1-Phenylethyl)aziridine-2-carboxylate esters in the synthesis of biologically relevant compounds.

Authors:  Iwona E Głowacka; Aleksandra Trocha; Andrzej E Wróblewski; Dorota G Piotrowska
Journal:  Beilstein J Org Chem       Date:  2019-07-23       Impact factor: 2.883

Review 3.  Epoxides: Small Rings to Play with under Asymmetric Organocatalysis.

Authors:  Sara Meninno; Alessandra Lattanzi
Journal:  ACS Org Inorg Au       Date:  2022-03-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.